Cite
HARVARD Citation
Kondo, S. et al. (n.d.). 314 Phase 1 study of abemaciclib, a CDK 4 and 6 inhibitor, as a single agent for Japanese patients with advanced cancer. European journal of cancer. pp. S59-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kondo, S. et al. (n.d.). 314 Phase 1 study of abemaciclib, a CDK 4 and 6 inhibitor, as a single agent for Japanese patients with advanced cancer. European journal of cancer. pp. S59-. [Online].